A complimentary, online educational series aimed to support ongoing education for physical therapist amidst COVID-19
Montreal, Quebec (March 24th, 2020) – Emovi, Inc., a global medical device company, announces today the launch of a new webinar series for physical therapists: Knee Pain and its Daily Care. The complimentary webinar series is designed as an educational program to address a variety of knee pain causes, patient impact, mechanics, and restoring function, specifically as physical therapy clinics seek to optimize their activities and time during the COVID-19 pandemic.
The complimentary series includes four, forty-five-minute webinar discussions, containing insights from experts Dr. Joseph A. Zeni, Jr., MSPT, Ph.D., Assistant Professor, Department of Physical Therapy
Rutgers University and Emovi’s Lead Medical Communication and Education Expert, Philippe Landry.
“Today, more than ever, it is imperative that we find new, innovative ways to help clinicians,” said CEO of Emovi, Michelle Laflamme. “Emovi’s free series of webinars will act as an extension of our practice, pro-actively serving health professionals with focused takeaways about common topics, from knee osteoarthritis to residual pain post-op.”
Join Emovi executives and industry experts for four weeks of interactive webinars on either Wednesdays or Fridays:
March 25th from 12h to 12h45 EST
March 27th from 12h to 12h45 EST
April 1st from 12h to 12h45 EST
April 3rd from 12h to 12h45 EST
April 8th from 12h to 12h45 EST
April 10th from 12h to 12h45 EST
April 15th from 12h to 12h45 EST
April 17th from 12h to 12h45 EST
To register for one or more of the upcoming webinars, send the following information to firstname.lastname@example.org:
A hyperlink to the webinar (via zoom) will be sent before the webinars.
About Emovi Inc.
Headquartered in Montreal, Emovi is a medical device company that develops products for knee joint assessment to restore patient quality of life. In partnership with the Quebec university research community, including the CRCHUM, École de Technologie supérieure (ÉTS), and TELUQ, Emovi completed the development of the KneeKG, a unique clinical tool evaluating knee functional deficiencies linked to patients’ symptoms and pathology progression. Emovi owns multiple patents and the exclusive worldwide license to commercialize KneeKG. https://emovi.ca
KneeKG is the first device that enables doctors to accurately assess patients’ knees in 3D while the patient is moving and weight-bearing. In contrast to static information provided by X-ray and magnetic resonance imaging (MRI), KneeKG quickly identifies the dynamic function of impaired knees allowing healthcare professionals to determine the most strategic treatment plan to restore the knee. By providing doctors with technical information that has a higher correlation to symptoms and at a fraction of the cost of high-tech scans such as MRIs, the KneeKG allows healthcare professionals to significantly improve patients’ quality of life while reducing pain and functional limitations.